KVPHQ Insider Trading Activity and SEC Form 4 Filings
KVPHQ insider trading summary
No open-market insider purchases or sales of Kv Pharmaceutical Co (KVPHQ) have been reported on SEC Form 4 in the past 12 months.
Latest KVPHQ insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 6, 2013 | Glenview Capital Management, LLC | 10% Owner | Buy | $820K (1,764,709 @ $0.46) |
| Aug 6, 2013 | Lawrence M Robbins | 10% Owner | Buy | $820K (1,764,709 @ $0.46) |
| Aug 2, 2013 | Lawrence M Robbins | 10% Owner | Buy | $387K (703,000 @ $0.55) |
| Aug 2, 2013 | Glenview Capital Management, LLC | 10% Owner | Buy | $387K (703,000 @ $0.55) |
| Aug 1, 2013 | Glenview Capital Management, LLC | 10% Owner | Buy | $464K (800,000 @ $0.58) |
| Aug 1, 2013 | Lawrence M Robbins | 10% Owner | Buy | $464K (800,000 @ $0.58) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.